Your session is about to expire
← Back to Search
Diagnostic Imaging for Coronary Heart Disease (SWAN Trial)
N/A
Waitlist Available
Led By Harmony Reynolds, M.D.
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women with positive cardiac markers and/or ST elevation scheduled for angiography
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one week of enrollment
Awards & highlights
SWAN Trial Summary
This trial will help doctors understand why some women have heart attacks even when they don't have any major blockages in their heart arteries.
Who is the study for?
This trial is for women who have had a heart attack or unstable angina and are scheduled for an angiography, but do not have major blockages in their heart arteries. Women with previous obstructive coronary artery disease, those who can't undergo IVUS or MRI procedures, or those using vasospastic agents cannot participate.Check my eligibility
What is being tested?
The study uses intravascular ultrasound (IVUS) to take pictures of the inside of arteries and magnetic resonance imaging (MRI) to assess blood flow and damage in the heart. It aims to understand why some women experience heart attacks despite having no significant blockage in their arteries.See study design
What are the potential side effects?
While this study does not involve drugs that could cause typical medication side effects, IVUS and MRI are generally safe but may include risks such as discomfort during the procedure, allergic reactions to contrast materials used, or complications from lying still during MRI.
SWAN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman with heart issues scheduled for a heart vessel check.
SWAN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within one week of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one week of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
IVUS and MRI findings
SWAN Trial Design
1Treatment groups
Experimental Treatment
Group I: WomenExperimental Treatment2 Interventions
IVUS and MRI performed in women with no obstructive CAD at angiography
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370
Intravascular ultrasound
2007
N/A
~160
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,373 Previous Clinical Trials
841,070 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
714 Patients Enrolled for Acute Coronary Syndrome
Doris Duke Charitable FoundationOTHER
62 Previous Clinical Trials
260,048 Total Patients Enrolled
Harmony Reynolds, M.D.Principal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with blocked arteries in my heart.You cannot have an intravascular ultrasound (IVUS) or magnetic resonance imaging (MRI) for medical reasons.I am taking medication for blood vessel spasms.I am a woman with heart issues scheduled for a heart vessel check.
Research Study Groups:
This trial has the following groups:- Group 1: Women
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger